Equities research analysts expect Imax Corp (NYSE:IMAX) to post $0.28 earnings per share for the current quarter, according to Zacks. Four analysts have made estimates for Imax’s earnings, with the highest EPS estimate coming in at $0.30 and the lowest estimate coming in at $0.26. Imax posted earnings of $0.30 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 6.7%. The business is scheduled to report its next earnings report after the market closes on Tuesday, July 30th.

On average, analysts expect that Imax will report full-year earnings of $1.14 per share for the current fiscal year, with EPS estimates ranging from $1.08 to $1.22. For the next year, analysts expect that the company will post earnings of $1.24 per share, with EPS estimates ranging from $1.13 to $1.30. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Imax.

Imax (NYSE:IMAX) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Imax had a net margin of 6.12% and a return on equity of 6.31%. The business had revenue of $80.20 million during the quarter, compared to analysts’ expectations of $81.29 million. During the same period last year, the company posted $0.21 EPS. The business’s revenue was down 5.6% on a year-over-year basis.

IMAX has been the subject of a number of recent analyst reports. Wedbush reaffirmed an “outperform” rating on shares of WNS in a research note on Tuesday, July 16th. Zacks Investment Research cut shares of EXACT Sciences from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. MKM Partners lifted their price target on shares of Imax to $28.00 and gave the stock a “buy” rating in a research note on Friday, April 12th. ValuEngine cut shares of Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. Finally, TheStreet cut shares of ZovioInc . from a “c-” rating to a “d” rating in a research note on Thursday, May 23rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $27.17.

Shares of IMAX stock traded down $0.17 during trading hours on Wednesday, reaching $21.28. 509 shares of the stock were exchanged, compared to its average volume of 325,145. Imax has a 12-month low of $17.55 and a 12-month high of $26.10. The stock’s 50-day moving average is $20.17. The company has a market cap of $1.32 billion, a price-to-earnings ratio of 38.30, a price-to-earnings-growth ratio of 1.37 and a beta of 0.98.

In other news, Director Darren D. Throop sold 3,301 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $20.21, for a total value of $66,713.21. Following the completion of the sale, the director now owns 8,341 shares in the company, valued at approximately $168,571.61. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kenneth Ian Weissman sold 4,077 shares of the business’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $24.90, for a total transaction of $101,517.30. Following the completion of the sale, the senior vice president now owns 7,426 shares of the company’s stock, valued at approximately $184,907.40. The disclosure for this sale can be found here. Insiders have sold a total of 50,975 shares of company stock valued at $1,157,092 in the last quarter. 20.20% of the stock is currently owned by company insiders.

Large investors have recently bought and sold shares of the company. Principal Financial Group Inc. grew its position in Imax by 29.8% during the 4th quarter. Principal Financial Group Inc. now owns 10,367 shares of the company’s stock worth $195,000 after purchasing an additional 2,379 shares during the last quarter. Norges Bank purchased a new stake in Imax during the 4th quarter worth approximately $18,169,000. Pembroke Management LTD grew its position in Imax by 26.5% during the 1st quarter. Pembroke Management LTD now owns 803,000 shares of the company’s stock worth $18,212,000 after purchasing an additional 168,350 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its position in Imax by 335.3% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 16,050 shares of the company’s stock worth $302,000 after purchasing an additional 12,363 shares during the last quarter. Finally, Two Sigma Advisers LP grew its position in Imax by 5.6% during the 4th quarter. Two Sigma Advisers LP now owns 374,000 shares of the company’s stock worth $7,035,000 after purchasing an additional 19,900 shares during the last quarter. Institutional investors and hedge funds own 75.07% of the company’s stock.

Imax Company Profile

IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in motion picture technologies and presentations worldwide. It offers cinematic solution comprising proprietary software, theater architecture, and equipment. The company engages in Digital Re-Mastering (DMR) of films into the IMAX format for exhibition in the IMAX theater network; the provision of IMAX premium theater systems to exhibitor customers through sales, long-term leases, and joint revenue sharing arrangements; the distribution of documentary films; the provision of production technical support and film post-production services; the ownership and operation of IMAX theaters; and the provision of camera and other miscellaneous items rental services.

Recommended Story: Risk Tolerance and Your Investment Decisions

Get a free copy of the Zacks research report on Imax (IMAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Imax (NYSE:IMAX)

Receive News & Ratings for Imax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax and related companies with MarketBeat.com's FREE daily email newsletter.